Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors

CONCLUSION: This risk stratification system based on tumor stage and the interval between treatment and normalization of AFP may help to guide clinical management by dividing OYST patients into three risk groups.PMID:37865050 | DOI:10.1016/j.ygyno.2023.10.006
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research